Literature DB >> 24165308

Acute amnesia and seizures in a young female.

María Eugenia García García1, Sergio Muñiz Castrillo1, Irene Garcia Morales1, Daniela Di Capua Sacoto1, Alberto Marcos Dolado1.   

Abstract

Limbic encephalitis is a condition characterised by an acute or sub-acute onset of memory disorder, associated with seizures and psychiatric manifestations. Investigations such as brain MRI usually reveal a high intensity signal in the medial temporal lobe and cerebrospinal fluid analysis shows mild pleocytosis and oligoclonal bands. It may occur in association with cancer, infection, or as an isolated clinical condition, often accompanying autoimmune disorders. Immune-mediated limbic encephalitis is now subclassified according to the presence and type of autoantibodies, which has significant consequences regarding the effectiveness of treatment and prognosis. Glutamic acid decarboxylase (GAD) is an enzyme that catalyses glutamic acid into gamma aminobutyric acid. Anti-GAD antibodies are associated with different neurological and non-neurological disorders, but only a few cases of limbic encephalitis associated with anti-GAD antibodies have been reported in the literature, most of them non-paraneoplastic. Here, we report the case of a young female patient with a medical history of psoriasis who developed an acute onset and chronic evolution of anterograde amnesia, associated with drug-resistant epilepsy. Brain MRI showed hyperintensity in the medial temporal lobes and the biochemical studies revealed intrathecal synthesis of anti-GAD antibodies. Screening tests for tumours were negative. Despite antiepileptic drugs, intravenous immunoglobulins and immunosuppressive treatment, the patient did not show clinical improvement and one year later, she continues to present refractory temporal epilepsy and cognitive deficits.

Entities:  

Keywords:  glutamic acid decarboxylase; immunotherapy; limbic encephalitis; paraneoplastic antibody

Mesh:

Substances:

Year:  2013        PMID: 24165308     DOI: 10.1684/epd.2013.0607

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN: 1294-9361            Impact factor:   1.819


  4 in total

1.  Familial autoimmunity in neurological patients with GAD65 antibodies: an interview-based study.

Authors:  Sergio Muñiz-Castrillo; Alberto Vogrig; Clémentine Montagnac; Bastien Joubert; Marie Benaiteau; Olivier Casez; Hugo Chaumont; Lucie Hopes; Hélène-Marie Lanoiselée; Vincent Navarro; Benjamin Thomas; Renata Ursu; David Gonçalves; Nicole Fabien; François Ducray; Cécile Julier; Jérôme Honnorat
Journal:  J Neurol       Date:  2021-02-05       Impact factor: 4.849

Review 2.  Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies.

Authors:  Matteo Gastaldi; Anaïs Thouin; Angela Vincent
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 3.  Anti-glutamic acid decarboxylase antibody positive neurological syndromes.

Authors:  Hassaan Tohid
Journal:  Neurosciences (Riyadh)       Date:  2016-07       Impact factor: 0.906

4.  Intravenous methylprednisolone or immunoglobulin for anti-glutamic acid decarboxylase 65 antibody autoimmune encephalitis: which is better?

Authors:  Tao-Ran Li; Yu-Di Zhang; Qun Wang; Xiao-Qiu Shao; Zhi-Mei Li; Rui-Juan Lv
Journal:  BMC Neurosci       Date:  2020-03-30       Impact factor: 3.288

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.